DNA encoding canine interleukin-1 receptor antagonist

Details DNA encoding canine interleukin-1 receptor antagonist DNA encoding canine interleukin-1 receptor antagonist

1997-05-23

2000-05-16

Draper, Garnette D.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

435 691, 435 695, 4352523, 4353201, 536 235, C12N 1524, C12N 1500

Patent

active

060636009

ABSTRACT:
Canine IL-1 receptor antagonist protein, DNAs, and expression vectors carrying DNA sequence encoding canine IL-1 receptor antagonist are disclosed.

REFERENCES:
patent: Re35450 (1997-02-01), Dower et al.
patent: 4894333 (1990-01-01), Cerretti et al.
patent: 4902708 (1990-02-01), Kim
patent: 4968607 (1990-11-01), Dower et al.
patent: 4975464 (1990-12-01), Imaki et al.
patent: 5075222 (1991-12-01), Hannum et al.
patent: 5081228 (1992-01-01), Dower et al.
patent: 5180812 (1993-01-01), Dower et al.
patent: 5196402 (1993-03-01), Braganza et al.
patent: 5220018 (1993-06-01), Bock et al.
patent: 5286739 (1994-02-01), Kilbourn et al.
patent: 5286847 (1994-02-01), Gehrke et al.
patent: 5296592 (1994-03-01), Dower et al.
patent: 5319071 (1994-06-01), Dower et al.
patent: 5334380 (1994-08-01), Kilbourn et al.
patent: 5350683 (1994-09-01), Sims et al.
patent: 5455330 (1995-10-01), Haskill et al.
patent: 5464937 (1995-11-01), Sims et al.
patent: 5488032 (1996-01-01), Dower et al.
patent: 5492888 (1996-02-01), Dower et al.
patent: 5508262 (1996-04-01), Norman
patent: 5552536 (1996-09-01), Nicholson et al.
patent: 5563046 (1996-10-01), Mascarenhas et al.
Lebedenko et al, Bioorg. Khim 1993, 19(8) 586-88.
Haskill et al, PNAS 1991, 88(a), 368-85.
Caron et al., "Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression," Arthritis and Rheumatism, 1996; 39:1535-1544.
Femandes, et al., "Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity," Arthritis and Rheumatism, 1997; 40:284-294.
Fischer, et al.,""Comparison between effects of interleukin-1 administration and sublethal endotoxemia in primates, the American Physiological Society, 1991:R442-R452.
Granowitz, et al., "Pharmacokinetics, Safety and Immunomodulatory Effects of Human Recombinant Interleukin-1 Receptor Antagonist in Healthy Humans," Cytokine, 1992 4(5):353-360.
Houssiau, "Cytokines in rheumatoid arthritis," Clinical Rheumatology, 1995 14 Suppl. 2:10-3.
Pickvance, et al., "Immunolocalization of selected cytokines and protease in canine articular cartilage after transarticular loading," J. of Ortho. Res., 1993; 11(3):313-323.
Shuster, et al., "Administration of recombinant human interleukin 1 receptor antagonist during endotoxin-induced mastitis in cows," American Journal of Veterinary Research, 1995; 56:313-320.
Charles A. Dinarello, M.D., Supplement to Nutrition, 1995, vol. 11, No. 5: 492-497.
C. H. Evans and P. D. Robbins, Annals of Medicine, 1995, 27:543-546.
J. Lewthwait, Journal of Rheumatology, Mar, 21(3):467-72.
Fabio Cominelli, The Journal of Biological Chemistry, Mar. 4, 1994, vol. 269, pp. 6962-6971.
GL Hung, Gene Thereapy, Jan. 1994, 1(1):64-9.
Kamyar A. Zahedi, Cytokine, Jan. 1994, vol. 6, No. 1, pp. 1-9.
Koichhi Aiura, Infection and Immunity, Aug. 1993, vol. 61, No. 8, pp. 3342-3350.
J. Martel-Pelletier, Biochimica et Biophsica Acta., Feb. 17, 1993, 1175(3):302-305.
James A. Lederer, Journal of Leukocyte Biology, Jun., 1992, vol. 51, pp. 586-590.
Eva Fischer, Journal of Clinical Investigation, May, 1992, vol. 89, pp. 1551-1557.
F. Goto, Immunology, 1992, vol. 77, pp. 235-244.
Andrew Lennard, Cytokine, Mar., 1992, vol. 4, No. 2, pp. 83-89.
Hitoshi Matsuchime, Blood, Aug. 1, 1991, vol. 78, No. 3, pp. 616-623.
Charles A. Dinarello, Blood, Apr. 15, 1991, vol. 77, No. 8, pp. 1627-1652.
Go Wakabayashi, The FASEB Journal, Mar., 1991, vol. 5, pp. 338-343.
S.P. Eisenberg, Proc. Natl. Acad. Sci. USA, Jun. 1991, Immunology, vol. 88, pp. 5232-5236.
Kjell Ohlsson, Nature, Dec. 6, 1990, vol. 348, pp. 550-552.
D. B. Carter, Nature, Apr. 12, 1990, vol. 344, pp. 633-638.
Stephen B. Eisenberg, Nature, Jan. 25, 1990, vol. 343, pp. 341-346.
E. J. Sillenaar Bilgen, Transplantation Proceedings, Feb., 1989, vol. 21, No. 1, pp. 2829-2830.
C. Natanson, Journal of clinical Investigation, Jan., 1989, 83(1):243-251.
Seijiro Okusawa, Journal of Clinical Investigation, Apr., 1988, vol. 81, pp. 1162-1172.
Anders Waage, Journal of Experimental Medicine, Jun., 1988, vol. 167, pp. 1987-1992.
H. Okayama, Molecular & Cellular Biology, Feb., 1983, 3(2):280-289.
W. David Benton, Science, vol. 196, Apr. 8, 1977, pp. 180-182.

Affiliated with

Also associated with

Rating

DNA encoding canine interleukin-1 receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DNA encoding canine interleukin-1 receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding canine interleukin-1 receptor antagonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-257830